| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.089 | 0.08 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.048 | 0.3 |